Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of fIPV Booster and Rotavirus Vaccines
NCT02847026Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Sep 2016
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by Centers for Disease Control and Prevention. Started Sep 2016; status: completed.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02847026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847026.